Clinical Cancer Research Bridging the Lab and the Clinic in Cancer Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoon, W.-H.
Right arrow Articles by Kim, Y. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoon, W.-H.
Right arrow Articles by Kim, Y. S.
Clinical Cancer Research Vol. 10, 4517-4526, July 1, 2004
© 2004 American Association for Cancer Research


Experimental Therapeutics, Preclinical Pharmacology

Gabexate Mesilate Inhibits Colon Cancer Growth, Invasion, and Metastasis by Reducing Matrix Metalloproteinases and Angiogenesis

Wan-Hee Yoon1,4, Yeon-Joo Jung1, Tae-Dong Kim2, Ge Li1, Byoung-Jeon Park1, Ji-Yeon Kim1, Young-Chul Lee2, Jin-Man Kim3,4, Jong-Il Park2, Hae-Duck Park1, Zae-Sung No5, Kyu Lim2,4, Byung-Doo Hwang2,4 and Young S. Kim6

Departments of 1 Surgery, 2 Biochemistry, and 3 Pathology, 4 Cancer Research Institute, Chungnam National University College of Medicine, Daejon, Korea; 5 Medicinal Science Division, Korea Research Institute of Chemical Technology, Daejon, Korea; and 6 Gastrointestinal Research Laboratory, Veterans Administration Medical Center, Department of Medicine and Pathology, University of California, San Francisco, California

Gabexate mesilate (GM), a synthetic protease inhibitor, has an antiproteinase activity on various types of plasma serine proteases. However, its role on matrix metalloproteinases (MMPs) has not been identified. In this study, we investigated the effect of GM on MMPs and on the invasion and metastasis of human colon cancer cell lines and neoangiogenesis. The activities of MMPs secreted from these cells were significantly reduced by GM but unaffected by the serine protease inhibitor aprotinin. GM directly inhibited purified progelatinase A derived from T98G human glioblastoma cells. In vitro, GM significantly reduced the invasive ability of colon cancer cells but not cellular motility, whereas aprotinin affected neither. Liver metastatic ability and tumorigenic potential in nude mice were remarkably reduced on treatment with GM. Immunohistochemical analysis of GM-treated tumors in mice showed a marked increase in apoptosis and a significant reduction in tumor angiogenesis. Human umbilical vein endothelial cell proliferation, tube formation, and neoangiogenesis in the rabbit cornea and Matrigel implanted in mice were significantly inhibited by GM. These results suggest that GM is a novel inhibitor of MMPs and that it may inhibit the invasion and metastasis of human colon cancer cells by blocking MMPs and neoangiogenesis.




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
C.-O. Yun, H.-C. Shin, T.-D. Kim, W.-H. Yoon, Y.-A Kang, H.-S. Kwon, S. K. Kim, and J.-S. Kim
Transduction of artificial transcriptional regulatory proteins into human cells
Nucleic Acids Res., September 1, 2008; 36(16): e103 - e103.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J.-S. Kim, Y.-C. Lee, H.-T. Nam, G. Li, E.-J. Yun, K.-S. Song, K.-S. Seo, J.-H. Park, J.-W. Ahn, O. Zee, et al.
Apicularen A Induces Cell Death through Fas Ligand Up-Regulation and Microtubule Disruption by Tubulin Down-Regulation in HM7 Human Colon Cancer Cells
Clin. Cancer Res., November 1, 2007; 13(21): 6509 - 6517.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.